trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
Honored master pioneers TCM’s future
2020-09-14
Zhang Boli (right), recipient of the national honorary title, the People's Hero, arrives at Chinese Academy of Engineering to attend a symposium held by the academy in Beijing, Sept 8, 2020. [Photo/chinadaily.com.cn]
Zhang Boli, 72, an academician of the Chinese Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, is a pioneer in modern development and high-quality use of Traditional Chinese Medicine (TCM).
During his 82 days spent in Wuhan, once China’s hardest-hit city by the novel coronavirus, he led a TCM expert medical team that helped the metropolis pull through its worst time.
With the efficacy TCM has shown in treating the virus, Zhang joined dozens of video sessions this year to share his TCM treatment experience on COVID-19 with medics in other countries.
China has now shared TCM therapy, effective prescriptions and clinical experience for tackling COVID-19 with more than 80 countries and regions, according to the National Administration of Traditional Chinese Medicine.
“The virus knows no boundaries and races. We are always open to sharing experiences. I hope TCM can help more and more people worldwide," Zhang said.
On Sept 8, Zhang attended a meeting held at the Great Hall of the People in Beijing, and was granted the national honorary title "People's Hero" for his outstanding contributions to the country's fight against the COVID-19 epidemic.
"This honor was not only given to me as an individual. I share the glory because I am a member of the medical staff who have benefited from TCM," Zhang said.
He is committed to pioneering TCM research with modern technology. “Paired with modern technology, TCM will achieve innovative and outstanding achievements."
Medical professionals hand out Lianhuaqingwen capsules to patients at a Fangcang Hospital in Wuhan, Central China's Hubei province in February. [Photo provided to chinadaily.com.cn]
Under his leadership a new national-level key research laboratory for traditional Chinese medicine was approved for the Tianjin University of Traditional Chinese Medicine.
The laboratory will be based at the world's largest traditional Chinese medicine component storage center at the institute, which is now home to 60,000 TCM components.
The institute is expected to release more than 80,000 TCM components and 5,000 TCM compounds over the next five years, which will facilitate development of new drugs based on TCM.
For Zhang, cultivating talents in TCM is a key focus for developing the traditional therapy.
More than 280 postdoctoral, doctoral and master's degree students have received his tutoring, most of whom have become backbones in the field.
At every year’s graduation ceremony of the university, Zhang insists on presenting the degrees in person to nearly 3,000 graduates. "There are some moments in life that cannot be ignored. Although I am tired for a few days, the students will remember this moment.”
“I hope that more Chinese medicine talents will start from here, learn something, and become doctors who save lives and care about patients."
Zhang has donated more than 4 million yuan (about $580,000) of the money he received from awards to set up a scholarship fund for elite TCM majors whose families are facing a financial crunch.
(China Daily)